tiprankstipranks
Fulcrum Therapeutics reports Q3 EPS (35c), consensus (41c)
PremiumThe FlyFulcrum Therapeutics reports Q3 EPS (35c), consensus (41c)
3M ago
Fulcrum Therapeutics expects cash to fund operations into at least 2027
Premium
The Fly
Fulcrum Therapeutics expects cash to fund operations into at least 2027
3M ago
Is FULC a Buy, Before Earnings?
Premium
Pre-Earnings
Is FULC a Buy, Before Earnings?
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
Goldman Sachs moves to Not Rated on Fulcrum Therapeutics after study failure
Premium
The Fly
Goldman Sachs moves to Not Rated on Fulcrum Therapeutics after study failure
5M ago
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
5M ago
Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyFulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink
5M ago
Fulcrum Therapeutics downgraded to Underperform from Neutral at BofA
Premium
The Fly
Fulcrum Therapeutics downgraded to Underperform from Neutral at BofA
5M ago
Fulcrum Therapeutics downgraded to Hold from Buy at Stifel
Premium
The Fly
Fulcrum Therapeutics downgraded to Hold from Buy at Stifel
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100